Actinium Pharmaceuticals Story Overview

ATNM -- USA Stock  

USD 0.69  0.06  9.92%

Macroaxis does not monitor all media channels or aggregates social signals for Actinium Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Actinium Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Actinium Pharmaceuticals. Check also Actinium Pharmaceuticals Hype Analysis, Actinium Pharmaceuticals Correlation and Actinium Pharmaceuticals Performance.
Acquisition or disposition of Actinium Pharmaceuticals securities by Nitya Ray
Filed transaction by Actinium Pharmaceuticals officer. Acquisition or disposition under rule 16b-3

Actinium Pharmaceuticals Inc insider trading alert for acquisition or disposition of series b warrants by Nitya Ray, Executive VP, on March 8, 2018. This event was filed by Actinium Pharmaceuticals with SEC on 2018-03-08. Statement of changes in beneficial ownership - SEC Form 4. Nitya Ray is currently serves as executive vice president head - product development, manufacturing and supply chain of Actinium Pharmaceuticals

Story Momentum

This media report from MacroaxisInsider distributed on March 8, 2018 was a factor to the next trading day price decrease.The overall trading delta against the next closing price was 0.02% . The overall trading delta when the story was published against the current closing price is 60.43% .

Similar stores for Actinium Pharmaceuticals

Important Factors to Analyse A Good Investment Actinium Pharmaceuticals Incnews
Alpha Beta StockWhich is more compelling pick right now Actinium Pharmaceuticals, Inc. , Athersys, Inc. StockNewsGazetteFull coverage
Actinium Pharmaceuticals, Inc. stock returned 66.46 percent up Monthly Gainernews
The Stocks News Full coverage
over a week ago at http://www.streetobserver.com 
Actinium Pharmaceuticals, Inc. stock gained 15.85 percent return Quarterly
news
Street Observer Full coverage
over a week ago at http://thewellesleysnews.com 
Analyzing Analyst Recommendations Spirit AeroSystems Holdings, Inc. , Actinium Pharmaceuticals, Inc.
news
Analyst JournalFull coverage
over two weeks ago at http://alphabetastock.com 
May This Data Fuel Up Investors Confidence Actinium Pharmaceuticals Inc
news
Alpha Beta StockFull coverage
over two weeks ago at http://www.stocksnewspoint.com 
50 days simple moving average in Focus Catalyst Pharmaceuticals, Inc. , Actinium ...
news
Stocks News Point Full coverage
over three weeks ago at http://friscofastball.com 
Institutional Investors Are Selling Actinium Pharmaceuticals Inc
news
Frisco FastballActinium Pharmaceuticals Inc Institutional Investors Sentiment Index Dropped in 2017 Q4 KL DailyFull coverage
over a month ago at http://www.stocksnewspoint.com 
Lloyds Banking Group plc , Agenus Inc. , Actinium Pharmaceuticals, Inc. NYSEATNM ...
news
Stocks News Point Full coverage
over a month ago at http://www.journalfinance.net 
Blustering Stocks Aralez Pharmaceuticals Inc. , Actinium Pharmaceuticals, Inc. NYSEATNM ...
news
Market Breaking Point Full coverage
over a month ago at http://mosttradedstocks.com 
Actinium Pharmaceuticals, Inc. Do You Have This Stock in Portfolio
news
MostTradedStocks Full coverage
over two months ago at http://topchronicle.com 
Do You Own Actinium Pharmaceuticals, Inc. Shares
news
Actinium Pharmaceuticals, Inc. closed its last session at 0.37. The stock traded within a range of 0.350 and 0.390. Investors watching Analysts Rating of Actinium Pharmaceuticals, Inc. - Wall Street Morning Which is more compelling pick right now Intelsat SA , Actinium ... - StockNewsGazette
over three months ago at http://alphabetastock.com 
Hair-Raising Facts to Know Actinium Pharmaceuticals Inc
news
Alpha Beta StockFull coverage

Did you try this?

Run Pair Correlation Now
   

Pair Correlation

Compare performance and examine historical correlation between any two equity instruments
All  Next Launch Pair Correlation

Working Capital

Working Capital Comparative Analysis
  Working Capital 
      Actinium Pharmaceuticals Comparables 
Actinium Pharmaceuticals is currently under evaluation in working capital category among related companies. Working Capital is measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Peers

Actinium Pharmaceuticals Related Equities
DMPI  16.46 %   
0%
100.0%
VBLT  10.00 %   
0%
60.0%
VCEL  6.36 %   
0%
38.0%
VBIV  5.28 %   
0%
32.0%
DRRX  5.13 %   
0%
31.0%
DMTX  0.00 %   
0%
0%
DNLI  0.95 %   
5.0%
0%
DOVA  4.71 %   
28.0%
0%
NK  6.83 %   
41.0%
0%
DRNA  7.69 %   
46.0%
0%
Check also Actinium Pharmaceuticals Hype Analysis, Actinium Pharmaceuticals Correlation and Actinium Pharmaceuticals Performance. Please also try Coins and Tokens Correlation module to utilize digital token correlation table to build portfolio of cryptocurrencies across multiple exchanges.